Download presentation
Presentation is loading. Please wait.
Published byEdward Lipiński Modified over 6 years ago
1
HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
Bob T. Li, M.B.B.S., MPH, Dara S. Ross, MD, Dara L. Aisner, MD, PhD, Jamie E. Chaft, MD, Meier Hsu, MS, Severine L. Kako, Mark G. Kris, MD, Marileila Varella-Garcia, PhD, Maria E. Arcila, MD Journal of Thoracic Oncology Volume 11, Issue 3, Pages (March 2016) DOI: /j.jtho Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
2
Figure 1 Representative images of lung adenocarcinoma with human epidermal growth factor receptor 2 gene (HER2) amplification: with hematoxylin and eosin staining and ×400 magnification (A) and fluorescence in situ hybridization using a HER2 IQFISH pharmDxTM probe, Dako (HER2 = red signal, CEP17 = green signal) (B). Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.